Autoimmune hemolytic anemia

Area of Science:

• Immunology
• Hematology
• Autoimmunity

Background:

• Autoimmune hemolytic anemia (AIHA) is characterized by autoantibodies against red blood cells (RBCs).
• Antibody types (IgG, IgM, IgA) and specificity (Rh, I, P) vary.
• Antibody behavior (complement fixation) influences RBC destruction pathways.

Purpose of the Study:

• To elucidate the characteristics of warm-type and cold-type autoantibodies in AIHA.
• To describe the mechanisms of RBC destruction mediated by different autoantibody types.
• To identify potential factors contributing to the breakdown of immunological tolerance in AIHA.

Main Methods:

• Classification of autoantibodies based on thermal type (warm/cold) and immunoglobulin class (IgG, IgM, IgA).
• Analysis of antibody specificity (e.g., Rh, I, P).
• Evaluation of complement (C) fixation and its role in RBC destruction.
• Assessment of RBC destruction sites (spleen, liver) and mechanisms (intravascular lysis, phagocytosis).

Main Results:

• Warm-type autoantibodies are typically Rh-specific IgG and do not fix complement, causing splenic RBC destruction.
• Cold-type antibodies include IgM (often anti-I) and Donath-Landsteiner (DL) IgG (anti-P) antibodies.
• IgM and DL antibodies can fix complement, leading to intravascular lysis or hepatic/splenic phagocytosis of C3-coated RBCs.

Conclusions:

• AIHA autoantibody characteristics dictate the pathogenesis and clinical presentation.
• Complement fixation is a key differentiator in RBC destruction mechanisms.
• Genetic factors, infections, drugs, and immune dysregulation likely contribute to AIHA development.